Diefenbach

ODAIA Adds Demonstrated Industry Talent Following Successful Series B

Retrieved on: 
Tuesday, June 6, 2023
Vaccine, Software as a service, Therapy, Marketing, Acceleration, Wave, H&R Block, Wave Financial, Michigan Israel Business Accelerator, Diefenbach, Veeva Systems, Acquisition, Patient, ARR, CFO, Growth, SVP, Rest, Nudge, Pharmaceutical industry, Management, Ostro

Rebecca Skvorc joined ODAIA as Chief Financial Officer, while Jim Diefenbach was named SVP of Sales and Mike Goulart as Sr. Director, Business Acceleration.

Key Points: 
  • Rebecca Skvorc joined ODAIA as Chief Financial Officer, while Jim Diefenbach was named SVP of Sales and Mike Goulart as Sr. Director, Business Acceleration.
  • Her responsibilities at ODAIA will include strategically positioning the company for its next phase of growth following its capital raise and a more than 646% increase in year-over-year annual recurring revenue (ARR) in 2022.
  • Previously, Diefenbach spent nearly a decade at Veeva Systems, the global leader in cloud software for the life sciences industry.
  • “We are extremely fortunate to be able to add successful industry veterans like Rebecca, Jim, and Mike to the ODAIA team during such an exciting time for our company.